Pediatrix Medical (MD) Gains from Investment Securities (2010 - 2026)

Pediatrix Medical has disclosed Gains from Investment Securities across 17 years of filings, most recently posting $670000.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 11.61% year-over-year to $670000.0; the TTM figure through Mar 2026 stood at $4.8 million (up 211.84% YoY), while the FY2025 annual figure was $1.4 million, down 1.17% from the prior year.
• Gains from Investment Securities retreated to $670000.0 in Q1 2026, from $975000.0 in the prior quarter.
• Over the last five years, Gains from Investment Securities for MD reached as high as $50.0 million in Q1 2022 and fell as low as -$5.9 million in Q1 2024.
• The 5-year median for Gains from Investment Securities is $800000.0 (2022), against an average of $4.3 million.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities jumped 7736.99% — and 2024, when it sank 1608.95%.
• A 5-year view of Gains from Investment Securities shows it stood at $11.0 million in 2022, then tumbled by 113.39% to -$1.5 million in 2023, then jumped by 259.93% to $2.4 million in 2024, then slumped by 58.67% to $975000.0 in 2025, then sank by 31.28% to $670000.0 in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $670000.0, $975000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.